Please use this identifier to cite or link to this item:
https://hdl.handle.net/10356/163940
Title: | Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia | Authors: | Zhang, Qian Matuozzo, Daniela Le Pen, Jérémie Lee, Danyel Moens, Leen Asano, Takaki Bohlen, Jonathan Liu, Zhiyong Moncada-Velez, Marcela Kendir-Demirkol, Yasemin Jing, Huie Bizien, Lucy Marchal, Astrid Abolhassani, Hassan Delafontaine, Selket Bucciol, Giorgia Bayhan, Gulsum Ical Keles, Sevgi Kiykim, Ayca Hancerli, Selda Haerynck, Filomeen Florkin, Benoit Hatipoglu, Nevin Ozcelik, Tayfun Morelle, Guillaume Zatz, Mayana Ng, Lisa F. P. Lye, David C. Young, Barnaby Edward Leo, Yee Sin Dalgard, Clifton L. Lifton, Richard P. Renia, Laurent Meyts, Isabelle Jouanguy, Emmanuelle Hammarström, Lennart Pan-Hammarström, Qiang Boisson, Bertrand Bastard, Paul Su, Helen C. Boisson-Dupuis, Stéphanie Abel, Laurent Rice, Charles M. Zhang, Shen-Ying Cobat, Aurélie Casanova, Jean-Laurent |
Keywords: | Science::Medicine | Issue Date: | 2022 | Source: | Zhang, Q., Matuozzo, D., Le Pen, J., Lee, D., Moens, L., Asano, T., Bohlen, J., Liu, Z., Moncada-Velez, M., Kendir-Demirkol, Y., Jing, H., Bizien, L., Marchal, A., Abolhassani, H., Delafontaine, S., Bucciol, G., Bayhan, G. I., Keles, S., Kiykim, A., ...Casanova, J. (2022). Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia. Journal of Experimental Medicine, 219(8), e20220131-. https://dx.doi.org/10.1084/jem.20220131 | Project: | COVID19RF-001 COVID19RF-0008 COVID19RF-060 H/20/04/g1/006 |
Journal: | Journal of Experimental Medicine | Abstract: | Recessive or dominant inborn errors of type I interferon (IFN) immunity can underlie critical COVID-19 pneumonia in unvaccinated adults. The risk of COVID-19 pneumonia in unvaccinated children, which is much lower than in unvaccinated adults, remains unexplained. In an international cohort of 112 children (<16 yr old) hospitalized for COVID-19 pneumonia, we report 12 children (10.7%) aged 1.5-13 yr with critical (7 children), severe (3), and moderate (2) pneumonia and 4 of the 15 known clinically recessive and biochemically complete inborn errors of type I IFN immunity: X-linked recessive TLR7 deficiency (7 children) and autosomal recessive IFNAR1 (1), STAT2 (1), or TYK2 (3) deficiencies. Fibroblasts deficient for IFNAR1, STAT2, or TYK2 are highly vulnerable to SARS-CoV-2. These 15 deficiencies were not found in 1,224 children and adults with benign SARS-CoV-2 infection without pneumonia (P = 1.2 × 10-11) and with overlapping age, sex, consanguinity, and ethnicity characteristics. Recessive complete deficiencies of type I IFN immunity may underlie ∼10% of hospitalizations for COVID-19 pneumonia in children. | URI: | https://hdl.handle.net/10356/163940 | ISSN: | 0022-1007 | DOI: | 10.1084/jem.20220131 | Rights: | © 2022 Zhang et al. This article is available under a Creative Commons License (Attribution 4.0 International, as described at https://creativecommons.org/licenses/by/4.0/) | Fulltext Permission: | open | Fulltext Availability: | With Fulltext |
Appears in Collections: | LKCMedicine Journal Articles SBS Journal Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia.pdf | 2.83 MB | Adobe PDF | View/Open |
SCOPUSTM
Citations
20
10
Updated on Jan 23, 2023
Web of ScienceTM
Citations
20
5
Updated on Jan 25, 2023
Page view(s)
68
Updated on Jan 27, 2023
Download(s)
6
Updated on Jan 27, 2023
Google ScholarTM
Check
Altmetric
Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.